Search research articles
Contact Us
Filters
Showing results (61-70 of 91) with videos related to
Page
of 10
Sort By:
The Journal of Rheumatology
|
May 3, 2016
Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting
Ana-Maria Orbai, Philip J Mease, Maarten de Wit, et al.
The Journal of Rheumatology
|
March 3, 2019
Core Outcome Sets Specifically for Longterm Observational Studies: OMERACT Special Interest Group Update in Rheumatoid Arthritis
Maria A Lopez-Olivo, José B Negrón, Richard J Zogala, et al.
Annals of the Rheumatic Diseases
|
December 2, 2016
The patient perspective on absence of disease activity in rheumatoid arthritis: a survey to identify key domains of patient-perceived remission
Lilian H D van Tuyl, Martina Sadlonova, Sarah Hewlett, et al.
Annals of the Rheumatic Diseases
|
June 5, 2026
Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials: a GRAPPA-OMERACT systematic review and network meta-analysis
Tommy K Annfeldt, Mina N Händel, Tobias Haugegaard, et al.
The Journal of Rheumatology
|
May 3, 2019
Identifying Possible Outcome Domains from Existing Outcome Measures to Inform an OMERACT Core Domain Set for Safety in Rheumatology Trials
Louise Klokker, Dorthe B Berthelsen, Thasia Woodworth, et al.
Seminars in Arthritis and Rheumatism
|
October 18, 2017
A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative
Pil Højgaard, Louise Klokker, Ana-Maria Orbai, et al.
Seminars in Arthritis and Rheumatism
|
January 6, 2026
Determining the best discriminatory physical functioning outcome measurement instrument for psoriatic arthritis trials: A meta-epidemiological study
Ying-Ying Leung, Tobias Haugegaard, Tommy Kok Annfeldt, et al.
Seminars in Arthritis and Rheumatism
|
January 23, 2021
Harms reported by patients in rheumatology drug trials: a systematic review of randomized trials in the cochrane library from an OMERACT working group
Dorthe B Berthelsen, Thasia G Woodworth, Niti Goel, et al.
The Journal of Rheumatology
|
March 2, 2021
Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group
Ying Ying Leung, Ana-Maria Orbai, William Tillett, et al.
The Journal of Rheumatology. Supplement
|
June 3, 2018
Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting
Richard Holland, William Tillett, Alexis Ogdie, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 91) with videos related to
Sort By:
Page
of 10
The Journal of Rheumatology
|
May 3, 2016
Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting
Ana-Maria Orbai, Philip J Mease, Maarten de Wit, et al.
The Journal of Rheumatology
|
March 3, 2019
Core Outcome Sets Specifically for Longterm Observational Studies: OMERACT Special Interest Group Update in Rheumatoid Arthritis
Maria A Lopez-Olivo, José B Negrón, Richard J Zogala, et al.
Annals of the Rheumatic Diseases
|
December 2, 2016
The patient perspective on absence of disease activity in rheumatoid arthritis: a survey to identify key domains of patient-perceived remission
Lilian H D van Tuyl, Martina Sadlonova, Sarah Hewlett, et al.
Annals of the Rheumatic Diseases
|
June 5, 2026
Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials: a GRAPPA-OMERACT systematic review and network meta-analysis
Tommy K Annfeldt, Mina N Händel, Tobias Haugegaard, et al.
The Journal of Rheumatology
|
May 3, 2019
Identifying Possible Outcome Domains from Existing Outcome Measures to Inform an OMERACT Core Domain Set for Safety in Rheumatology Trials
Louise Klokker, Dorthe B Berthelsen, Thasia Woodworth, et al.
Seminars in Arthritis and Rheumatism
|
October 18, 2017
A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative
Pil Højgaard, Louise Klokker, Ana-Maria Orbai, et al.
Seminars in Arthritis and Rheumatism
|
January 6, 2026
Determining the best discriminatory physical functioning outcome measurement instrument for psoriatic arthritis trials: A meta-epidemiological study
Ying-Ying Leung, Tobias Haugegaard, Tommy Kok Annfeldt, et al.
Seminars in Arthritis and Rheumatism
|
January 23, 2021
Harms reported by patients in rheumatology drug trials: a systematic review of randomized trials in the cochrane library from an OMERACT working group
Dorthe B Berthelsen, Thasia G Woodworth, Niti Goel, et al.
The Journal of Rheumatology
|
March 2, 2021
Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group
Ying Ying Leung, Ana-Maria Orbai, William Tillett, et al.
The Journal of Rheumatology. Supplement
|
June 3, 2018
Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting
Richard Holland, William Tillett, Alexis Ogdie, et al.
Page
of 10